DGAP: Developmental Genome Anatomy Project
DGAP:发育基因组解剖项目
基本信息
- 批准号:6881388
- 负责人:
- 金额:$ 156.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Applicant's Abstract): The goal of the Developmental
Genome Anatomy Project (DGAP) is to identify genes critical in human
development that are disrupted or dysregulated by balanced chromosomal
rearrangements in humans with multiple congenital anomalies. Approximately 1 in
2000 newborns has an apparently balanced rearrangement, with a 6.1 percent risk
for a serious congenital anomaly. These anomalies can include isolated defects
ranging from cleft palate/lip, abdominal wall defects, limb defects, cardiac
abnormalities or mental retardation, or they can occur as part of clinically
recognizable syndromes. Of particular relevance is the fact that de novo
structural abnormalities involving all chromosomes have been reported in
association with congenital anomalies; it has been speculated that a
significant number of such chromosomal breaks directly disrupt or dysregulate
genes critical to specific molecular pathways. We propose to study individuals
with multiple congenital anomalies and apparently balanced chromosomal
rearrangements, with the aim of using balanced chromosomal rearrangements as
signposts to identify these critical genes. The potential of DGAP will be
greatly enhanced by rapidly evolving genomic resources including the complete
human DNA sequence and an ordered FISH BAC map of the human genome.
Collaborations established between cytogeneticists and clinical geneticists
across the medical genetics community have been established to collect patient
samples with a variety of developmental defects and balanced chromosomal
rearrangements. Analysis of chromosomal breakpoints through FISH mapping
studies will be used to identify single genomic clones containing relevant
candidate sequences, and an online DGAP database is being created (Project 1).
Molecular identification and analysis of candidate genes, as well as mutation
studies in affected individuals will be the focus of subsequent studies
(Project 2). Identification of expression patterns assessing tissue or temporal
specificity will follow, as well as isolation of homologs in M. musculus and D.
melanogaster (Project 3). Ultimately, transgenic animals will be used to study
specific clones of interest to elucidate more fully their role in development
(Project 3). DGAP constitutes a multi-laboratory and multi-institutional
research endeavor which brings together the disciplines of clinical genetics,
cytogenetics, molecular biology and developmental genetics to illuminate genes
involved in fundamental pathways during human development.
描述(申请人摘要):发展的目标
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cynthia Casson Morton其他文献
Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis
研究子宫肌瘤和乳腺癌的共同遗传结构:全基因组跨性状分析
- DOI:
10.1016/j.ajhg.2022.05.015 - 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Xueyao Wu;Chenghan Xiao;Zhitong Han;Li Zhang;Xunying Zhao;Yu Hao;Jinyu Xiao;C Scott Gallagher;Peter Kraft;Cynthia Casson Morton;Jiayuan Li;Xia Jiang - 通讯作者:
Xia Jiang
Cynthia Casson Morton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cynthia Casson Morton', 18)}}的其他基金
SEQuencing a Baby for an Optimal Outcome (SEQaBOO)
对婴儿进行测序以获得最佳结果 (SEQaBOO)
- 批准号:
9021176 - 财政年份:2016
- 资助金额:
$ 156.81万 - 项目类别:
相似海外基金
The pathogenesis of ALG14-congenital disorders of glycosylation.
ALG14-先天性糖基化障碍的发病机制。
- 批准号:
23K14967 - 财政年份:2023
- 资助金额:
$ 156.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying New Therapeutics and Molecular Mechanisms in Congenital Disorders of Glycosylation.
确定先天性糖基化疾病的新疗法和分子机制。
- 批准号:
10644811 - 财政年份:2023
- 资助金额:
$ 156.81万 - 项目类别:
Investigating the Genotype-Phenotype Relationships that Underlie Congenital Disorders with Cardiovascular Symptoms through Population-scale Analyses
通过人群规模分析研究具有心血管症状的先天性疾病背后的基因型-表型关系
- 批准号:
10724185 - 财政年份:2023
- 资助金额:
$ 156.81万 - 项目类别:
Identifying understudied protein-related glycoproteome disruption in Congenital Disorders of Glycosylation
识别先天性糖基化障碍中尚未研究的蛋白质相关糖蛋白组破坏
- 批准号:
10725869 - 财政年份:2023
- 资助金额:
$ 156.81万 - 项目类别:
Pathogenic Mechanisms of Congenital Disorders of Glycosylation
先天性糖基化障碍的发病机制
- 批准号:
10633548 - 财政年份:2023
- 资助金额:
$ 156.81万 - 项目类别:
Assessment of a potential application of endogenous stem cells to treat congenital disorders
评估内源干细胞治疗先天性疾病的潜在应用
- 批准号:
22K20740 - 财政年份:2022
- 资助金额:
$ 156.81万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
- 批准号:
10480649 - 财政年份:2022
- 资助金额:
$ 156.81万 - 项目类别:
Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)
靶向醛糖还原酶:依帕司他新用途治疗先天性糖基化障碍 (PMM2-CDG) 的 IIb/III 期试验
- 批准号:
10616658 - 财政年份:2022
- 资助金额:
$ 156.81万 - 项目类别:
O-glycosylation mechanisms of neurological deficits in congenital disorders of glycosylation
先天性糖基化障碍神经功能缺损的O-糖基化机制
- 批准号:
10040788 - 财政年份:2020
- 资助金额:
$ 156.81万 - 项目类别:
O-glycosylation mechanisms of neurological deficits in congenital disorders of glycosylation
先天性糖基化障碍神经功能缺损的O-糖基化机制
- 批准号:
10250486 - 财政年份:2020
- 资助金额:
$ 156.81万 - 项目类别:














{{item.name}}会员




